§ BIOTECHNOLOGY
USD · BiotechnologyTSHA
TAYSHA GENE THERAPIES INC
USDSector · BiotechnologyBeta · 1.28
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
146 increased/new, 46 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 6.10 | EPS (TTM) | -0.38 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 23.6M | 1.1% | ±0% |
| Goldman Sachs | 22.4M | 0.0% | n/a |
| Avoro Capital Advisors LLC | 21.7M | 1.0% | n/a |
| BlackRock, Inc. | 18.4M | 0.0% | −1% |
| Vestal Point Capital, LP | 18.0M | 2.2% | +31% |
| Morgan Stanley | 18.0M | 0.0% | n/a |
◇ AC INTELLIGENCE
Top institutional owners for TSHA as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER84.3% · 0 holders
OTHER8.9% · 123 holders
DEALER / BANK3.4% · 20 holders
PASSIVE / INDEX1.5% · 9 holders
QUALITY / COMPOUNDER1.0% · 16 holders
ACTIVIST0.3% · 1 holder
TACTICAL / MACRO0.2% · 5 holders
INCOME / DEFENSIVE0.2% · 12 holders
SYSTEMATIC / QUANT0.1% · 7 holders
GROWTH / MOMENTUM0.0% · 1 holder
DEEP VALUE0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for TSHA in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention TSHA yet.